Summit Therapeutics Inc.
SMMT
Rang în acțiuni
#1684
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering,... Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Preț acțiune
$15.60
Capitalizare de piață
$12.44B
Schimbare (1 zi)
-1.45%
Schimbare (1 an)
-18.58%
Țară
US
Tranzacționează Summit Therapeutics Inc. (SMMT)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Summit Therapeutics Inc. (SMMT)
Cel mai mare preț de închidere: $16.35 pe 2026-10-01
Cel mai mic preț de închidere: $11.32 pe 2015-03-01
Cel mai mic preț de închidere: $11.32 pe 2015-03-01
Istoric al prețului acțiunii pentru Summit Therapeutics Inc. din 2015 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | -6.38% |
| 2025 | -2.36% |
| 2024 | 648.94% |
| 2023 | -27.28% |
| 2022 | -16.52% |
| 2021 | -23.50% |
| 2020 | 244.19% |
| 2019 | 23.13% |
| 2018 | -88.74% |
| 2017 | 19.67% |
| 2016 | -15.67% |
| 2015 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $531.67 | 24.68% |
US
|
|
| $237.10 | 783.04% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $895.07 | 9.94% |
NL
|
|
| $288.17 | 1.24% |
BE
|
